Law channel feed – Endpoints News

Law channel feed

Will feds reclassify 'magic mushroom' therapies? Seattle doctor ramps up court battle

3 years ago

Takeda sues Apotex over prospective generic versions of its top leukemia drug

3 years ago

Clinical trial coordinators sentenced to prison after data falsification scheme

3 years ago

Big Pharma PACs blanket the election field with millions in contributions ahead of midterms

3 years ago

Investors who lost money from Neil Woodford's fund file lawsuit against investment platform

3 years ago

Senators call on NIH to take action on slow-to-report clinical trial sponsors

3 years ago

Pfizer petitions Supreme Court over anti-kickback case, says prior opinions could 'cut off charitable or family aid'

3 years ago

Supreme Court rejects Novartis' request for stay in Gilenya patent battle

3 years ago

Advocacy group and former antitrust official look to comment on Illumina's controversial Grail merger

3 years ago

Eli Lilly and Teva prepare for court battle over migraine med rivalry

3 years ago

After coverage restrictions for Alzheimer's drugs, bipartisan House bill would force CMS to review drugs individually

3 years ago

New inflation-linked drug rebates go into effect on Saturday

3 years ago

Industry groups call to block WTO IP waiver expansion to Covid-19 therapeutics

3 years ago

Merck celebrates another win in Januvia patent battle against Viatris

3 years ago

Senate passes bill to rework animal testing requirements for drug developers

3 years ago

Gilead names 'kingpins' in counterfeit HIV med lawsuit

3 years ago

Biogen pays $900M to settle wide-ranging physician kickback claims

3 years ago

New drug price law could help Part D enrollees who can't fill cancer treatments due to costs, White House says

3 years ago

Should SCOTUS hear Amgen's Repatha case? Solicitor general says no

3 years ago

Merck pulls a patent win for diabetes franchise in West Virginia federal court

3 years ago

FDA's OCE makes the case for accelerated approval rider in user fee reauthorization

3 years ago

Novartis takes Gilenya fight to Supreme Court as generic competition looms

3 years ago

J&J talc plaintiffs petition federal court to block the pharma's 'Texas two-step' maneuver

3 years ago

Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar

3 years ago

First page Previous page 26 27 282930 31 32 Next page Last page